Table 5.
Reference scenario (standard of care) | New scenario (epigenetic assay) | |||
---|---|---|---|---|
Cost | Total annual cost, $ | PMPM cost, $ | Total annual cost, $ | PMPM cost, $ |
Total cost of epigenetic assay | 0 | 0 | 1,623,143 | 0.14 |
Total cost of repeated biopsies | 2,864,142 | 0.33 | 710,198 | 0.06 |
Total cost of repeated biopsies avoided | 0 | 0 | 2,152,276 | 0.18 |
Total diagnostic cost to health plan | 2,864,142 | 0.24 | 2,333,341 | 0.19 |
Total diagnostic cost per patient | 3172 | 0.24 | 2584 | 0.19 |
Total budget impact to plan | −530,801 | |||
Total budget impact to plan PMPM | −0.442 |
PMPM indicates per member per month.